Botulinum toxin effects on gasatrocnemius strength and plantar pressure in diabetics with peripheral neuropathy and forefoot ulceration

Foot and Ankle International

Volumn 33, Issue 5, 2012, Pages 363-370

  Hastings, Mary K ^a   Mueller, Michael J ^a   Sinacore, David R ^a   Strube, Michael J ^a   Crowner, Beth E ^a   Johnson, Jeffrey E ^a   Racette, Brad R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BoNT A; Botulinum toxin A; Diabetes mellitus; Peripheral nervous system diseases

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROCNEMIUS MUSCLE; HUMAN; MALE; MUSCLE STRENGTH; PERIPHERAL NEUROPATHY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; SOLEUS MUSCLE;

BOTULINUM TOXINS, TYPE A; DIABETIC FOOT; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOREFOOT, HUMAN; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; PILOT PROJECTS; PRESSURE; PROSPECTIVE STUDIES;

EID: 84861464942     PISSN: 10711007     EISSN: None     Source Type: Journal    
DOI: 10.3113/FAI.2012.0363     Document Type: Article

References (35)

1. World Health Organization. http://www who int/diabetes/en/ 2011; Available at: URL: http://www.who.int/diabetes/en/.
2. Ansiaux, R; Baudelet, C; Cron, GO; et al.: Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clin Cancer Res. 12:1276-83, 2006. http://dx.doi.org/10.1158/1078-0432.CCR-05-1222
3. Apelqvist, J; Ragnarson-Tennvall, G; Larsson, J; Persson, U: Longterm costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int. 16:388-94, 1995.
4. Barry, DC; Sabacinski, KA; Habershaw, GM; Giurini, JM; Chrzan, JS: Tendo Achillis procedures for chronic ulcerations in diabetic patients with transmetatarsal amputations. J Am Podiatr Med Assoc. 83:96-100, 1993.
5. Boulton, AJ; Hardisty, CA; Betts, RP; et al.: Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care. 6:26-33, 1983. http://dx.doi.org/10.2337/diacare.6.1.26
6. Cade, WT: Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 88:1322-35, 2008. http://dx.doi.org/10. 2522/ptj.20080008
7. Delbridge, L; Perry, P; Marr, S; et al.: Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabet Med. 5:333-7, 1988. http://dx.doi.org/10.1111/j.1464-5491.1988.tb01000.x
8. Diamond, JE; Mueller, MJ; Delitto, A; Sinacore, DR: Reliability of a diabetic foot evaluation. Phys Ther. 69:797-802, 1989.
9. Fock, J; Galea, MP; Stillman, BC; Rawicki, B; Clark, M: Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Inj. 18:57-63, 2004. http://dx.doi.org/10.1080/0269905031000149498
10. Gordois, A; Scuffham, P; Shearer, A; Oglesby, A; Tobian, JA: The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. Diabetes Care. 26:1790-5, 2003. http://dx.doi.org/10.2337/diacare.26.6.1790
11. Hartmann, A; Knols, R; Murer, K; de Bruin, ED: Reproducibility of an isokinetic strength-testing protocol of the knee and ankle in older adults. Gerontology. 55:259-68, 2009. http://dx.doi.org/10.1159/000172832
12. Hastings, MK; Mueller, MJ; Sinacore, DR; et al.: Effects of a tendo-Achilles lengthening procedure on muscle function and gait characteristics in a patient with diabetes mellitus. J Orthop Sports Phys Ther. 30:85-90, 2000.
13. Hilton, TN; Tuttle, LJ; Bohnert, KL; Mueller, MJ; Sinacore, DR: Excessive Adipose Tissue Infiltration in Skeletal Muscle in Individuals With Obesity, Diabetes Mellitus, and Peripheral Neuropathy: Association With Performance and Function. Physical Therapy. 88:1336-44, 2008. http://dx.doi.org/10.2522/ptj. 20080079
14. Kirazli, Y; On, AY; Kismali, B; Aksit, R: Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial.[see comment]. American Journal of Physical Medicine & Rehabilitation. 77:510-5, 1998. http://dx.doi.org/10.1097/ 00002060-199811000-00012
15. Lin, SS; Lee, TH; Wapner, KL: Plantar forefoot ulceration with equinus deformity of the ankle in diabetic patients: the effect of tendo-Achilles lengthening and total contact casting. Orthopedics. 19:465-75, 1996.
16. Maluf, KS; Mueller, MJ; Strube, MJ; Engsberg, JR; Johnson, JE: Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait. J Biomech. 37:897-906, 2004. http://dx.doi.org/10.1016/j.jbiomech.2003.10.009
17. Mancini, F; Sandrini, G; Moglia, A; Nappi, G; Pacchetti, C: A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurological Sciences. 26(1):26-31, 2005. http://dx.doi.org/10.1007/s10072-005- 0378-9
18. Matic, DB; Lee, TY; Wells, RG; Gan, BS: The effects of botulinum toxin type A on muscle blood perfusion and metabolism. Plast Reconstr Surg. 120:1823-33, 2007. http://dx.doi.org/10.1097/01.prs.0000287135.17291.2f
19. Meyers-Rice, B; Sugars, L; McPoil, T; Cornwall, MW: Comparison of three methods for obtaining plantar pressures in nonpathologic subjects. J Am Podiatr Med Assoc. 84:499-504, 1994.
20. Mueller, MJ; Diamond, JE; Delitto, A; Sinacore, DR: Insensitivity, Limited Joint Mobility, and Plantar Ulcers in Patients with Diabetes-Mellitus. Physical Therapy. 69:453-9, 1989.
21. Mueller, MJ; Minor, SD; Sahrmann, SA; Schaaf, JA; Strube, MJ: Differences in the gait characteristics of patients with diabetes and peripheral neuropathy compared with age-matched controls. Phys Ther. 74:299-308, 1994.
22. Mueller, MJ; Sinacore, DR; Hastings, MK; Strube, MJ; Johnson, JE: Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am. 85-A:1436-45, 2003.
23. Odergren, T; Hjaltason, H; Kaakkola, S; et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry. 64:6-12, 1998. http://dx.doi.org/10.1136/ jnnp.64.1.6
24. Oskarsson, E; Piehl, AK; Gustafsson, BE; Pettersson, K: Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment. Scandinavian Journal of Medicine & Science in Sports. 19:323-8, 2009. http://dx.doi.org/10.1111/j.1600-0838.2008.00804.x
25. Pauri, F; Boffa, L; Cassetta, E; Pasqualetti, P; Rossini, PM: Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study. J Neurol Sci. 181:89-97, 2000. http://dx.doi.org/10.1016/ S0022-510X(00)00439-1
26. Pittock, SJ; Moore, AP; Hardiman, O; et al.: A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 15:289-300, 2003. http://dx.doi. org/10.1159/000069495
27. Ramsey, SD; Newton, K; Blough, D; et al.: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 22:382-7, 1999. http://dx.doi.org/10.2337/diacare.22.3.382
28. Rao, SR; Saltzman, CL; Wilken, J; Yak, HJ: Increased passive ankle stiffness and reduced dorsiflexion range of motion in individuals with diabetes mellitus. Foot Ankle Int. 27:617-22, 2006.
29. Reddy, GK: Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit achilles tendon. Experimental Diabesity Research. 5:143-53, 2004. http://dx.doi.org/10.1080/15438600490277860
30. Reiber, GE; Boyko, EJ; Smith, DG: Lower extremity foot ulcers and amputations in individuals with diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, editors. Diabetes in America. 2nd ed. Washington DC: US Government Printing Office; 1995. p. 408-28.
31. Reuter, I; Lorbach, O; Mehnert, S; Kaps, M; Engelhardt, M: Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery. Knee Surg Sports Traumatol Arthrosc. 18:265-8, 2010. http://dx.doi.org/10.1007/s00167-009- 0948-0
32. Simpson, DM; Gracies, J-M; Graham, HK; et al.: Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidencebased review): Report of Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 70:1691-8, 2008. http://dx.doi.org/10.1212/01.wnl. 0000311391.00944.c4
33. Turcotte, LP; Fisher, JS: Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise. Phys Ther. 88:1279-96, 2008. http://dx.doi.org/10.2522/ptj.20080018
34. Turkel, CC; Bowen, B; Liu, J; Brin, MF: Pooled Analysis of the Safety of Botulinum Toxin Type A in the Treatment of Poststroke Spasticity. Archives of Physical Medicine and Rehabilitation. 87:786-92, 2006. http://dx.doi.org/10. 1016/j.apmr.2006.02.015
35. Webber, SC; Porter, MM: Reliability of ankle isometric, isotonic, and isokinetic strength and power testing in older women. Physical Therapy. 90:1165-75, 2010.